{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T04:05:43Z","timestamp":1750478743116,"version":"3.41.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"30","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006631","name":"Animal and Plant Health Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006631","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.vaccine.2020.05.033","type":"journal-article","created":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T10:59:11Z","timestamp":1590145151000},"page":"4755-4761","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["The effect of BCG vaccination on macrophage phenotype in a mouse model of intranasal Mycobacterium bovis challenge"],"prefix":"10.1016","volume":"38","author":[{"given":"Alexander N.","family":"Civello","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Spiropoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro J.","family":"S\u00e1nchez-Cord\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Hicks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip J.","family":"Hogarth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin","family":"Birch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"N\u00fa\u00f1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.05.033_b0005","series-title":"Tuberculosis, leprosy and mycobacterial diseases of man and animals: the many hosts of mycobacteria","first-page":"17","article-title":"Comparative mycobacteriology of the Mycobacterium tuberculosis complex","author":"Gordon","year":"2015"},{"key":"10.1016\/j.vaccine.2020.05.033_b0010","unstructured":"Department for Environment, Food and Rural Affairs (DEFRA). Monthly publication of Official Statistics on the incidence and prevalence of tuberculosis (TB) in Cattle in Great Britain \u2013 to end August 2019. https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/845940\/bovinetb-statsnotice-monthly-13nov19.pdf; 2019 [accessed 13 November 2019]."},{"key":"10.1016\/j.vaccine.2020.05.033_b0015","unstructured":"Department for Environment, Food and Rural Affairs (DEFRA). A strategy for achieving Bovine Tuberculosis Free Status for England: 2018 review. https:\/\/www.gov.uk\/government\/publications\/a-strategy-for-achieving-bovine-tuberculosis-free-status-for-england-2018-review; 2018 [accessed 16 February 2018]."},{"key":"10.1016\/j.vaccine.2020.05.033_b0020","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1016\/j.vaccine.2012.02.018","article-title":"Bovine tuberculosis vaccine research: historical perspectives and recent advances","volume":"30","author":"Waters","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.05.033_b0025","series-title":"Tuberculosis, leprosy and mycobacterial diseases of man and animals: the many hosts of mycobacteria","first-page":"433","article-title":"Of mice and mycobacteria: lessons from a manipulatable model","author":"Cooper","year":"2015"},{"key":"10.1016\/j.vaccine.2020.05.033_b0030","doi-asserted-by":"crossref","first-page":"6994","DOI":"10.1128\/IAI.72.12.6994-7004.2004","article-title":"Long-term control of Mycobacterium bovis BCG infection in the absence of toll-like receptors (TLRs): investigation of TLR2-, TLR6-, or TLR2-TLR4-deficient mice","volume":"72","author":"Nicolle","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.05.033_b0035","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.1016\/j.vaccine.2005.07.037","article-title":"Frequency of IFN-\u03b3 producing cells correlates with adjuvant enhancement of bacille Calmette-Gu\u00e8rin induced protection against Mycobacterium bovis","volume":"23","author":"Logan","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.05.033_b0040","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jinf.2005.12.017","article-title":"Protective efficacy of intranasal vaccination with Mycobacterium bovis BCG against airway Mycobacterium tuberculosis challenge in mice","volume":"53","author":"Giri","year":"2006","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2020.05.033_b0045","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.vaccine.2005.07.115","article-title":"Protective efficacy induced by Mycobacterium bovis bacille Calmette-Gu\u00e8rin can be augmented in an antigen independent manner by use of non-coding plasmid DNA","volume":"24","author":"Hogarth","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.05.033_b0050","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.vaccine.2006.09.088","article-title":"Oral vaccination of mice with lipid-encapsulated Mycobacterium bovis BCG: effect of reducing or eliminating BCG load on cell-mediated immunity","volume":"25","author":"Cross","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.05.033_b0055","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/ni.1671","article-title":"Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens","volume":"9","author":"El Kasmi","year":"2008","journal-title":"Nature Immunol"},{"key":"10.1016\/j.vaccine.2020.05.033_b0060","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1128\/CVI.00018-08","article-title":"Immune response induced by three Mycobacterium bovis BCG substrains with diverse regions of deletion in a C57BL\/6 mouse model","volume":"15","author":"Irwin","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2020.05.033_b0065","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.1128\/IAI.00019-08","article-title":"Mycobacterium bovis BCG immunization induces protective immunity against nine different Mycobacterium tuberculosis strains in mice","volume":"76","author":"Jeon","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.05.033_b0070","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/eji.200737905","article-title":"Mycobacterium bovis BCG-infected neutrophils and dendritic cells cooperate to induce specific T cell responses in humans and mice","volume":"38","author":"Morel","year":"2008","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2020.05.033_b0075","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2249.2009.03923.x","article-title":"Mycobacterium bovis with different genotypes and from different hosts induce dissimilar immunopathological lesions in a mouse model of tuberculosis","volume":"157","author":"Aguilar Le\u00f3n","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2020.05.033_b0080","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1128\/CVI.00394-14","article-title":"Intranasal administration of Mycobacterium bovis BCG induces superior protection against aerosol infection with Mycobacterium tuberculosis in mice","volume":"21","author":"Derrick","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2020.05.033_b0085","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/978-1-4614-6111-1_7","article-title":"Cytokines in the balance of protection and pathology during mycobacterial infections","volume":"783","author":"Torrado","year":"2013","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.vaccine.2020.05.033_b0090","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1084\/jem.175.4.1111","article-title":"Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages","volume":"175","author":"Chan","year":"1992","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2020.05.033_b0095","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.immuni.2010.05.007","article-title":"Alternative activation of macrophages: mechanism and functions","volume":"32","author":"Gordon","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2020.05.033_b0100","first-page":"151","article-title":"FIZZ1 and Ym as tools to discriminate between differentially activated macrophages","volume":"9","author":"Raes","year":"2002","journal-title":"Dev Immunol"},{"key":"10.1016\/j.vaccine.2020.05.033_b0105","doi-asserted-by":"crossref","first-page":"13725","DOI":"10.1016\/S0021-9258(17)36703-0","article-title":"Regulation of biosynthesis of nitric oxide","volume":"269","author":"Nathan","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2020.05.033_b0110","doi-asserted-by":"crossref","first-page":"5347","DOI":"10.4049\/jimmunol.160.11.5347","article-title":"Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase\/arginase balance: competitive regulation by CD4+ T cells correlates with Th1\/Th2 phenotype","volume":"160","author":"Munder","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2020.05.033_b0115","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.vetmic.2011.02.025","article-title":"Alternative activation modifies macrophage resistance to Mycobacterium bovis","volume":"151","author":"Castillo-Velazquez","year":"2011","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2020.05.033_b0120","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.vetimm.2013.04.010","article-title":"Differential responses of macrophages from bovines naturally resistant or susceptible to Mycobacterium bovis after classical and alternative activation","volume":"154","author":"Castillo-Velazquez","year":"2013","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2020.05.033_b0125","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/imm.12097","article-title":"Tumour necrosis factor receptors and apoptosis of alveolar macrophages during early infection with attenuated and virulent Mycobacterium bovis","volume":"139","author":"Rodrigues","year":"2013","journal-title":"Immunol"},{"key":"10.1016\/j.vaccine.2020.05.033_b0130","doi-asserted-by":"crossref","first-page":"886","DOI":"10.14348\/molcells.2015.0125","article-title":"NMAAP1 expressed in BCG-activated macrophage promotes M1 macrophage polarization","volume":"38","author":"Liu","year":"2015","journal-title":"Mol Cells"},{"key":"10.1016\/j.vaccine.2020.05.033_b0135","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.tube.2008.05.005","article-title":"Development of a Mycobacterium bovis intranasal challenge model in mice","volume":"88","author":"Logan","year":"2008","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.vaccine.2020.05.033_b0140","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.micpath.2014.10.002","article-title":"Delayed presence of alternatively activated macrophages during Francisella tularensis infection","volume":"78","author":"D\u2019Elia","year":"2015","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2020.05.033_b0145","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.rvsc.2005.03.006","article-title":"Histopathogenesis of experimental Mycobacterium bovis infection in mice","volume":"80","author":"Chambers","year":"2006","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.vaccine.2020.05.033_b0150","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1111\/tbed.12561","article-title":"Differential cell composition and cytokine expression within lymph node granulomas from BCG-vaccinated and non-vaccinated cattle experimentally infected with Mycobacterium bovis","volume":"64","author":"Salguero","year":"2016","journal-title":"Transbound Emerg Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20306630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20306630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T18:29:13Z","timestamp":1750444153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20306630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":30,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0264410X20306630"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.05.033","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of BCG vaccination on macrophage phenotype in a mouse model of intranasal Mycobacterium bovis challenge","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.05.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2020 Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}